( ( ( ( ( Trans ( fatty acids ) ) ( have ( been ( implicated ( as ( ( a ( risk factor ) ) ( in ( coronary ( heart disease ) ) ) ) ) ) ) ) ) and ) ( ( methods ( to ( reduce ( their levels ) ) ) ) ( will ( be ( important ( to ( ( ( the consumer ) and ) ( the ( fat ( and ( oil industry ) ) ) ) ) ) ) ) ) ) ) . )
(ROOT (S (S (NP (NNP Trans) (NN fatty) (NNS acids)) (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN as) (NP (NP (DT a) (NN risk) (NN factor)) (PP (IN in) (NP (JJ coronary) (NN heart) (NN disease))))))))) (CC and) (S (NP (NNS methods) (S (VP (TO to) (VP (VB reduce) (NP (PRP$ their) (NNS levels)))))) (VP (MD will) (VP (VB be) (ADJP (JJ important) (PP (TO to) (NP (NP (DT the) (NN consumer)) (CC and) (NP (DT the) (NN fat) (CC and) (NN oil) (NN industry)))))))) (. .)))
Trans fatty acids have been implicated as a risk factor in coronary heart disease and methods to reduce their levels will be important to the consumer and the fat and oil industry.
(ROOT (S (NP (NNP Trans) (NNS fats)) (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN heart) (NN disease)))))))) (. .)))